Global Expansion The collaboration to launch GammaBeam Teletherapy System in Asia signals a strong international growth path and presents new market opportunities with IMRT/SBRS capabilities for hospitals, cancer centers, and research facilities in APAC and beyond; leverage TeamBest Global network for distribution and local partnerships.

Advanced Therapy Portfolio A dual focus on external beam systems such as Equinox and GammaBeam 100-80 provides a compelling upsell to clinics seeking modern, versatile radiotherapy with built-in MLC. Target mid-sized cancer centers upgrading from older units and groups evaluating IMRT/SBRS adoption.

Research Labs Self-contained irradiators including Gammacell models meet lab and biotech research needs, offering expansion opportunities with universities, CROs, and industrial irradiation applications; align sales toward research facilities expanding irradiation capabilities.

Partnership Engine As part of the TeamBest family with Asia-based partnerships, there is a ready-made channel strategy to accelerate market entry and service delivery through existing distributors and regional teams; consider co-marketing, localized regulations, and after-sales support.

Value Oriented Position GammaBeam 100-80 as an economical universal care option and highlight the built-in electronic MLC for precise dose delivery; emphasize total cost of ownership, service support, and compatibility with diverse clinical settings to win budget-constrained facilities.